glp 1 drugs while breastfeeding with GLP-1 Medication: Safety Insights Is semaglutide use during breastfeeding
Description
Although their potential for weight loss has long been recognized, FDA approval for obesity treatment has only occurred within the past decade [58]
10.1007/s40501-024-00331-y
However, there remains uncertainty about the efficiency of GLP-1 RAs in patients with heart failure (HF)
Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) have cardiovascular benefits in type 2 diabetes, but none of the cardiovascular trials studied atrial fibrillation/atrial flutter (AF) as a primary endpoint
Unlike some other countries, U.S
